Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Non-Invasive Imaging Detects Cancer at Molecular Level

By LabMedica International staff writers
Posted on 20 Aug 2019
For cancer patients the presence of metastases dictates the staging assessment, which in turn defines the appropriate treatment path selected. More...
For gynecological malignancies, like ovarian carcinoma, it is of immense importance to differentiate between localized and metastatic disease status as that drastically affects management.

For in situ, real time diagnosis, novel imaging modalities that offer metabolic and structural information at the cellular and subcellular level can be of great help, especially since these modalities are being progressively incorporated in probes and micro-endoscopes that allow intra-vital access to organs that lie deeper in the body.

Biomedical scientists at Tufts University (Medford, MA, USA) and their colleagues collected samples from eight patients who underwent open laparotomy as part of routine medical care. Post completion of all intra-abdominal procedures of the operation, eight biopsies of healthy parietal peritoneum and if present of four peritoneal metastases were collected from each patient. All lesions were evaluated by a pathologist using standard hematoxylin and eosin histology.

The tissues were imaged employing a multiphoton laser scanning microscope to generate intrinsic fluorescence and second harmonic generation (SHG) images at 755 nm and 900 nm excitation respectively with signal emission collected at 460 ± 20 and 525 ± 25 nm. Laser light was focused on the sample using a 25x objective (0.9 NA / water-immersion), and neutral density filters were employed to achieve a power of 25–35 mW. At least two to three random fields per tissue were evaluated, reaching a total of 30 and 11 images for the healthy and metastatic biopsy tissue groups, respectively (512 × 512 pixels; 600-micron field of view; resolution of 1.17 microns per pixel). Imaging was focused within a depth of ∼20-100 microns from the mesothelial surface of the tissues.

The team found that healthy tissues displayed large variations in contrast and correlation features as a function of distance, corresponding to repetitive, increased local intensity fluctuations. Metastatic tissue images exhibited decreased contrast and correlation related values, representing more uniform intensity patterns and smaller fibers, indicating the destruction of the healthy stroma by the cancerous infiltration. Analyzing 41 images acquired from the biopsies, the technique correctly classified 40 out of 41 images (an accuracy of 97.5%). A total of 11 samples were correctly classified as metastatic (100% sensitivity) and 29 of 30 were correctly classified as healthy (96.6% specificity).

Dimitra Pouli, MD, PhD, a Pathology Resident and co-author of the study, said, “The method utilized in this work identifies in a completely label-free manner cellular and tissue features at the microscopic level, essentially acting like a biopsy without a knife,” The study was published in the August 2019 issue of the journal Biomedical Optics Express.

Related Links:
Tufts University


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Automated PCR System
OnePCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.